Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 6/20 | 1.00 |
| ▸ | ACHE | P22303 | 7/20 | 0.59 |
| ▸ | CASP2 | P42575 | 1/20 | 0.57 |
| ▸ | MGLL | Q99685 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28335637 | 1.00 | EPHX1 (1.00) | EPHX1ACHECASP2MGLL | |
| SCHEMBL27052567 | 1.00 | EPHX1 (1.00) | EPHX1ACHECASP2MGLL | |
| SCHEMBL28556990 | 1.00 | EPHX1 (1.00) | EPHX1ACHECASP2MGLL | |
| SCHEMBL10118264 | 1.00 | EPHX1 (1.00) | EPHX1ACHECASP2MGLL | |
| SCHEMBL13387440 | 1.00 | EPHX1 (1.00) | EPHX1ACHECASP2MGLL | |
| SCHEMBL13387508 | 1.00 | EPHX1 (1.00) | EPHX1ACHECASP2MGLL | |
| SCHEMBL1616893 | 1.00 | EPHX1 (1.00) | EPHX1ACHECASP2MGLL | |
| SCHEMBL3910901 | 1.00 | EPHX1 (1.00) | EPHX1ACHECASP2MGLL | |
| SCHEMBL22693961 | 1.00 | EPHX1 (1.00) | EPHX1ACHECASP2MGLL | |
| SCHEMBL13387583 | 1.00 | EPHX1 (1.00) | EPHX1ACHECASP2MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119985745-A | Detection method for micromolecular phenolic substances and application thereof | 北京中医药大学 | 2025-05-13 | — | — | CN | claimed |
| CN-112724088-A | Uracil compound and anti-tumor application thereof | 中国医学科学院医药生物技术研究所 | 2021-04-30 | — | — | CN | claimed |
| CN-112618550-A | Antineoplastic uracil compound and lipid composition thereof | 中国医学科学院医药生物技术研究所 | 2021-04-09 | — | — | CN | claimed |
| CN-103391813-B | Isocyanate compound catalyst for producing and use the manufacture method of isocyanate compound of this catalyst | UBE INDUSTRIES, LTD. (JP) | 2016-04-13 | — | — | CN | claimed |
| CN-119985745-A | Detection method for micromolecular phenolic substances and application thereof | 北京中医药大学 | 2025-05-13 | — | — | CN | disclosed |
| WO-2024050742-A1 | BIFUNCTIONAL COMPOUNDS FOR DEGRADING KRAS G12D VIA UBIQUITIN PROTEASOME PATHWAY | NIKANG THERAPEUTICS, INC. (US) | 2024-03-14 | — | — | WO | disclosed |
| EP-4325622-A1 | SECONDARY BATTERY ELECTROLYTE SOLUTION AND SECONDARY BATTERY | Murata Manufacturing Co., Ltd. (JP) | 2024-02-21 | — | — | EP | disclosed |
| WO-2023115203-A1 | OXER1 ANTAGONISTS AND USES THEREOF | FAIRHAVEN PHARMACEUTICALS INC. (CA) | 2023-06-29 | — | — | WO | disclosed |
| CN-112020493-B | Method for producing urethane and method for producing isocyanate | 旭化成株式会社 | 2023-04-21 | — | — | CN | disclosed |
| WO-2022255018-A1 | SECONDARY BATTERY ELECTROLYTE SOLUTION AND SECONDARY BATTERY | 株式会社村田製作所 | 2022-12-08 | — | — | WO | disclosed |
| CN-112724088-B | Uracil compound and anti-tumor application thereof | 中国医学科学院医药生物技术研究所 | 2022-04-29 | — | — | CN | disclosed |
| US-11224679-B2 | Methods and compositions for dental tissue repair and/or regeneration | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-01-18 | — | — | US | disclosed |
| EP-0672653-B1 | Process for producing isocyanates | MITSUBISHI GAS CHEMICAL CO (JP) | 1998-01-14 | — | — | EP | disclosed |
| US-5541229-A | ANGIOITENSIN II ANTAGONIST AS HYPOTENSIVE AGENTS, ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS | DR. KARL THOMAE GMBH (DE) | 1996-07-30 | — | — | US | disclosed |
| US-5502244-A | DECOMPOSING A CARBAMATE WITH SULFONIC ACID CATALYST | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1996-03-26 | — | — | US | disclosed |
| EP-0672653-A1 | Process for producing isocyanates | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1995-09-20 | — | — | EP | disclosed |
| US-4581430-A | Acrylate and methacrylate polymers and processes for preparing them | ARMSTRONG WORLD INDUSTRIES, INC. (US) | 1986-04-08 | — | — | US | disclosed |
| US-4525302-A | FROM N-CHLORO-LACTAMS, AMIDES, AND CARBAMATES | ARMSTRONG WORLD INDUSTRIES, INC. (US) | 1985-06-25 | — | — | US | disclosed |
| US-4492619-A | FOR PREPARING POLYMER FILMS | ARMSTRONG WORLD INDUSTRIES, INC., A CORP. OF PA | 1985-01-08 | — | — | US | disclosed |
| US-4386033-A | BOILING, CONDENSATION OF VAPORS, CIRCULATION; SEPARATION | BAYER AKTIENGESELLSCHAFT (DE) | 1983-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11224679-B2 | Methods and compositions for dental tissue repair and/or regeneration | ICAM1, EPCAM, MKI67 | EPHX1 320/4885ACHE 1956/4885CASP2 605/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.